Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEM-BEAT: Semaglutide for Weight Management Across the Binge Eating Spectrum
NCT07870538Phase 4Recruiting
- Sponsor
- UZ Leuven
- Start
- Aug 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in obesity, sponsored by UZ Leuven. Started Aug 2026; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07870538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07870538.